Kursprognose für Denali Therapeutics Inc (DNLI)DNLIDenali Therapeutics Inc

Alphio's DNLI stock price prediction model matches the current Denali Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.99 (+0.66%). The 1-week path is $17.95 (+0.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Denali Therapeutics Inc (DNLI) appears to be a good buy right now due to its current price of $19.45, which is significantly below analyst price targets ranging from $30 to $36, indicating a potential upside of approximately 54% to 85%. Additionally, the company has a strong gross margin of 76.61% reported in Q2 2026, suggesting effective cost management and product sales growth. However, the main risk is the ongoing net losses, with a net margin of -3539.21%, which indicates significant operational challenges that need to be addressed.

Denali Therapeutics Inc (DNLI) last closed at $17.87, losing -2.88%. These facts feed the 1-day and 1-week DNLI price prediction above.